Ascelia Pharma
Ascelia Pharma is a clinical-stage pharmaceutical company focused on developing novel drugs for unmet medical needs in oncology and related conditions. The company specializes in orphan oncology treatments, with a pipeline that includes innovative, proprietary drug candidates designed to improve patient outcomes where current therapies are limited or unavailable. Ascelia Pharma’s lead asset targets diagnostic imaging for patients with impaired kidney function, aiming to enhance diagnostic accuracy and safety. Committed to rigorous research and development, Ascelia Pharma collaborates with healthcare professionals and industry partners to advance its mission of delivering effective, safe, and accessible therapies to patients worldwide.
